Cardinal Health, Inc. (CAH) Shares Bought by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 6.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,409,051 shares of the company’s stock after purchasing an additional 81,569 shares during the quarter. UBS Asset Management Americas Inc. owned 0.45% of Cardinal Health worth $109,793,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in Cardinal Health by 3.8% during the first quarter. Vanguard Group Inc. now owns 23,201,310 shares of the company’s stock worth $1,892,067,000 after purchasing an additional 843,212 shares during the last quarter. BlackRock Inc. lifted its stake in Cardinal Health by 6.5% during the second quarter. BlackRock Inc. now owns 22,843,418 shares of the company’s stock worth $1,779,958,000 after purchasing an additional 1,398,496 shares during the last quarter. State Street Corp lifted its stake in Cardinal Health by 1.1% during the first quarter. State Street Corp now owns 16,790,201 shares of the company’s stock worth $1,369,247,000 after purchasing an additional 176,331 shares during the last quarter. Franklin Resources Inc. lifted its stake in Cardinal Health by 72.1% during the second quarter. Franklin Resources Inc. now owns 6,283,529 shares of the company’s stock worth $489,613,000 after purchasing an additional 2,632,836 shares during the last quarter. Finally, FMR LLC lifted its stake in Cardinal Health by 47.1% during the first quarter. FMR LLC now owns 5,915,289 shares of the company’s stock worth $482,391,000 after purchasing an additional 1,895,089 shares during the last quarter. Hedge funds and other institutional investors own 87.63% of the company’s stock.
Shares of Cardinal Health, Inc. (NYSE:CAH) opened at 66.73 on Thursday. The firm has a 50-day moving average price of $67.69 and a 200 day moving average price of $74.72. Cardinal Health, Inc. has a 12 month low of $62.70 and a 12 month high of $84.88. The firm has a market capitalization of $21.12 billion, a price-to-earnings ratio of 16.56 and a beta of 0.85.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion for the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. Cardinal Health’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.14 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post $4.96 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be paid a $0.4624 dividend. This represents a $1.85 annualized dividend and a yield of 2.77%. The ex-dividend date is Friday, September 29th. Cardinal Health’s dividend payout ratio is 45.79%.
CAH has been the topic of several research analyst reports. Vetr cut Cardinal Health from a “buy” rating to a “hold” rating and set a $77.92 price objective on the stock. in a research note on Thursday, June 1st. ValuEngine cut Cardinal Health from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Zacks Investment Research upgraded Cardinal Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 20th. Evercore ISI restated an “outperform” rating on shares of Cardinal Health in a research note on Tuesday, July 4th. Finally, BidaskClub cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 11th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $76.81.
Cardinal Health Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.